Target intelligence / Profile preview

Vibrio cholerae O1 Inaba O-specific polysaccharide antigen (OSP)

Target
OSP
Molecular classification
Polysaccharide, Bacterial surface antigen, Lipopolysaccharide component
01

Overview

The Vibrio cholerae O1 Inaba O-specific polysaccharide (OSP) is a critical surface component of the lipopolysaccharide (LPS) found in the Inaba serotype of Vibrio cholerae O1, the primary causative agent of epidemic cholera [1]. Structurally, it is a homopolymer of alpha(1-2)-linked 4-amino-4,6-dideoxy-D-mannose (D-perosamine) units, which are N-acylated with 3-deoxy-L-glycero-tetronic acid [2]. The Inaba serotype is distinguished from the Ogawa serotype by the absence of a 2-O-methyl group on the non-reducing terminal perosamine residue [2,3]. Biologically, the OSP is essential for maintaining the structural integrity of the bacterial outer membrane and serves as the dominant target for the host's protective immune response [1,4]. Antibodies directed against the OSP, particularly vibriocidal antibodies, are strongly correlated with protection against infection and are the primary mechanism by which oral cholera vaccines (OCVs) confer immunity [3,5]. Consequently, OSP is a central component in the formulation of killed whole-cell vaccines and is a major focus for the development of next-generation conjugate vaccines aimed at providing long-term mucosal protection [4,6]. Sources: [1] Chatterjee & Chaudhuri (2003) Biochim Biophys Acta; [2] Villeneuve et al. (2000) PNAS; [3] WHO (2017) Cholera vaccines: WHO position paper; [4] Grandy et al. (2021) Front Immunol; [5] Harris et al. (2012) Lancet; [6] Xu et al. (2011) Bioconjug Chem.

Other names
Inaba O-antigenVibrio cholerae O1 Inaba O-antigenV. cholerae O1 Inaba O-specific polysaccharideVibrio cholerae O1 Inaba LPS O-antigen
02

Mechanism of action

Induction of protective vibriocidal antibodies and mucosal IgA that inhibit bacterial colonization and promote pathogen clearance [3,5].

03

Biological functions

Bacterial cell wall integritySerotype determinationImmune evasionProtection against environmental stress
04

Disease associations

CholeraInfection
05

Safety considerations

Serotype switching (Inaba to Ogawa)Limited cross-reactivity with O139 serogroupPotential for vaccine-induced selective pressure
06

Interacting drugs

Dukoral

3 more in the full profile.

07

Biomarkers

Vibriocidal antibody titerAnti-OSP IgG levelsAnti-OSP IgA levels

Beyond the preview

Go deeper on Vibrio cholerae O1 Inaba O-specific polysaccharide antigen (OSP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vibrio cholerae O1 Inaba O-specific polysaccharide antigen (OSP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call